StockGlow

Wuhan YZY Biopharma Co., Ltd. (2496.HK)

Wuhan YZY Biopharma Co., Ltd., a biotechnology company, develops bispecific antibody-based therapies for the treatment of cancer, cancer-associated complications, and age-related ophthalmologic diseases.

3.69-0.03%Healthcare
Compare 2496.HK with
StockGlow Score
3
Bearish
BearishBullish
1 year ago-34.1%

The outlook

Wuhan YZY Biopharma Co., Ltd. currently reads as bearish based on below its 50- & 200-day averages, 0% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$740.7M
52-wk high
8.40
52-wk low
3.69
50-day avg
4.08
200-day avg
5.87
Trailing P/E
—

Similar stocks

2480.HKBeijing Luzhu Biotechnology Co., Ltd.$14.00+0.00%2481.HKSL Gemini Energy Co., Ltd$2.57+0.00%2418.HKDeewin Tianxia Co., Ltd$2.80+3.70%2487.HKCutia Therapeutics$2.34-2.50%2482.HKLogory Logistics Technology Co., Ltd.$0.52+13.04%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy